MedTrace Logo

Upper Sequential Distalization With TADs and Aligners

NCT04875104 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2021-11-04

No results posted yet for this study

Summary

In this study the investigators are going to compare the predictability of the backward movement of upper first molars in patients with the upper dentition more advanced than the lower dentition. The investigators are going to study if the movements that they predict are achieved and in which proportion and compare it between four different aligner systems. The investigators hypothesis is that there are no differences in the predictability of this movement between the four aligner systems.

Conditions

  • Malocclusion, Angle Class II
  • Distalization

Interventions

DEVICE

Orthodontic treatment with Invisalign system

Patients are going to receive an orthodontic treatment with Invisalign aligners.

DEVICE

Orthodontic treatment with Spark system

Patients are going to receive an orthodontic treatment with Spark aligners.

DEVICE

Orthodontic treatment with Quicksmile system

Patients are going to receive an orthodontic treatment with Quicksmile aligners.

DEVICE

Orthodontic treatment with ClearCorrect system

Patients are going to receive an orthodontic treatment with ClearCorrect aligners.

Sponsors & Collaborators

  • Universidad Complutense de Madrid

    lead OTHER

Principal Investigators

  • Alejandro Iglesias Linares · Universidad Complutense de Madrid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-05-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04875104 on ClinicalTrials.gov